2082 related articles for article (PubMed ID: 8282789)
1. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
[TBL] [Abstract][Full Text] [Related]
2. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
3. Platelet adhesion.
Packham MA; Mustard JF
Prog Hemost Thromb; 1984; 7():211-88. PubMed ID: 6397767
[TBL] [Abstract][Full Text] [Related]
4. Increased platelet deposition on atherosclerotic coronary arteries.
van Zanten GH; de Graaf S; Slootweg PJ; Heijnen HF; Connolly TM; de Groot PG; Sixma JJ
J Clin Invest; 1994 Feb; 93(2):615-32. PubMed ID: 8113399
[TBL] [Abstract][Full Text] [Related]
5. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
6. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
7. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor.
Shenkman B; Linder N; Savion N; Tamarin I; Dardik R; Kennet G; German B; Varon D
Pediatr Res; 1999 Feb; 45(2):270-5. PubMed ID: 10022601
[TBL] [Abstract][Full Text] [Related]
8. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
Wielders SJ; Broers J; ten Cate H; Collins PW; Bevers EM; Lindhout T
Thromb Haemost; 2009 Jul; 102(1):76-82. PubMed ID: 19572071
[TBL] [Abstract][Full Text] [Related]
9. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
Salatti JA; Anton P; Nemerson Y; Sakariassen KS
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
[TBL] [Abstract][Full Text] [Related]
11. The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI.
Bonnefoy A; Harsfalvi J; Pfliegler G; Fauvel-Lafève F; Legrand C
Thromb Haemost; 2001 Mar; 85(3):552-9. PubMed ID: 11307830
[TBL] [Abstract][Full Text] [Related]
12. Platelet-vessel wall interaction in health and disease.
Löwenberg EC; Meijers JC; Levi M
Neth J Med; 2010 Jun; 68(6):242-51. PubMed ID: 20558854
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions.
Sugita C; Yamashita A; Moriguchi-Goto S; Furukoji E; Takahashi M; Harada A; Soeda T; Kitazawa T; Hattori K; Tamura S; Asada Y
Thromb Res; 2009 Nov; 124(5):601-7. PubMed ID: 19660789
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin (DDAVP) enhances platelet adhesion to the extracellular matrix of cultured human endothelial cells through increased expression of tissue factor.
Gálvez A; Gómez-Ortiz G; Díaz-Ricart M; Escolar G; González-Sarmiento R; Zurbano MJ; Ordinas A; Castillo R
Thromb Haemost; 1997 May; 77(5):975-80. PubMed ID: 9184413
[TBL] [Abstract][Full Text] [Related]
18. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components.
Sakariassen KS; Aarts PA; de Groot PG; Houdijk WP; Sixma JJ
J Lab Clin Med; 1983 Oct; 102(4):522-35. PubMed ID: 6619647
[TBL] [Abstract][Full Text] [Related]
19. alpha-thrombin bound to extracellular endothelial matrix induces pronounced fibrin deposition and platelet thrombus growth in flowing non-anticoagulated human blood.
Salatti JA; Fenton J; Anton P; Sakariassen KS
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):561-6. PubMed ID: 7841312
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
